Ruifeng Xu

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 1

Top Topics

Small Cell Lung Cancer

Top Venues

Molecular cancer therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Bin Shen, Jueping Shi, Zhixuan Zhu, Zhidong He, Shenyan Liu, Wan Shi, Yongxian Zhang, Haiyan Ying, Jie Wang, Ruifeng Xu, Fei Fang, Harrison Xuesong Chang, Zhui Chen, Nannan Zhang
EGFR inhibition overcomes resistance to FGFR4 inhibition and potentiates FGFR4 inhibitor therapy in hepatocellular carcinoma. Molecular cancer therapeutics (2023)